Litcius/Paper detail

Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma

Yasuhiro Ito, Akira Miyauchi

2023Journal of the Endocrine Society16 citationsDOIOpen Access PDF

Abstract

Active surveillance for low-risk papillary thyroid microcarcinoma (PTMC; T1aN0MI) was initiated at Kuma Hospital (Kobe, Japan) in 1993, based on a proposal by Akira Miyauchi. Favorable outcomes of such surveillance have been reported. Our latest study revealed 5- and 10-year tumor enlargement rates (by ≥ 3 mm) of 3.0% and 5.5% and 5- and 10-year node metastasis appearance rates of 0.9% and 1.1%, respectively. The postoperative prognosis did not differ between patients who underwent immediate surgery and those who underwent conversion surgery after progression. These findings suggest that active surveillance may be the best initial management of PTMCs.

Topics & Concepts

MedicineThyroidDistant metastasisSurgeryRadiologyGeneral surgeryMetastasisCancerInternal medicineThyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid SurgeryPituitary Gland Disorders and Treatments
Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma | Litcius